{"id":"W4411411712","doi":"10.1016/j.ard.2025.05.683","title":"POS0296 MYOCARDIAL INFARCTION, STROKE, VENOUS THROMBOEMBOLIC EVENTS, SERIOUS INFECTIONS AND MALIGNANCY IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH TOFACITINIB COMPARED TO BIOLOGIC TREATMENTS IN THE UNITED STATES","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Medicine; Tofacitinib; Psoriatic arthritis; Myocardial infarction; Malignancy; Stroke (engine); Dermatology; Arthritis; Internal medicine; Rheumatoid arthritis; Surgery; Cardiology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008852902,0.000229194,0.0004737441,0.0005570251,0.0002766697,0.0007766707,0.0001739955,0.0003145891,0.002489038],"category_scores_gemma":[0.003073987,0.0002062322,0.001060452,0.001237741,0.0001384574,0.0003898504,0.0003548482,0.000800643,0.0002088387],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002728686,"about_ca_system_score_gemma":0.0004022837,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002455298,"about_ca_topic_score_gemma":0.003167415,"domain_scores_codex":[0.9988623,0.0003586945,0.0002084167,0.0002606404,0.0002077781,0.0001023008],"domain_scores_gemma":[0.9973382,0.0004337061,0.001749971,0.00008799622,0.0001001075,0.0002900191],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005543491,0.0001666132,0.9870772,0.0001479208,0.0009006911,0.0001258359,0.00005184568,0.0001021297,0.0002450368,0.00005280642,0.0006753355,0.004911048],"study_design_scores_gemma":[0.0004578827,0.001035535,0.9960151,0.00004546245,0.0005356774,0.0005102381,0.0001340435,0.0004072885,0.00008755959,0.00009892388,0.0006635707,0.000008667647],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951465,0.001463637,0.00008554792,0.0001196414,0.00004084166,0.00001924873,0.002198905,0.000005354379,0.0009203356],"genre_scores_gemma":[0.9978124,0.0004485298,0.00006550761,0.00008766029,0.00004915356,0.00001886175,0.001369904,0.000001906136,0.0001460904],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002489038,"threshold_uncertainty_score":0.00832665,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01250673021705631,"score_gpt":0.2731981105292067,"score_spread":0.2606913803121504,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}